Rahul Khairnar

474 total citations
25 papers, 308 citations indexed

About

Rahul Khairnar is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rahul Khairnar has authored 25 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rahul Khairnar's work include Prostate Cancer Diagnosis and Treatment (7 papers), Radiation Therapy and Dosimetry (6 papers) and Chronic Disease Management Strategies (4 papers). Rahul Khairnar is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (7 papers), Radiation Therapy and Dosimetry (6 papers) and Chronic Disease Management Strategies (4 papers). Rahul Khairnar collaborates with scholars based in United States, Switzerland and Canada. Rahul Khairnar's co-authors include Mark V. Mishra, Eberechukwu Onukwugha, C. Daniel Mullins, Štefan Varga, Vincent J. Giannetti, Nilanjana Dwibedi, Khalid M. Kamal, Joseph Levy, Graeme F. Woodworth and Shifeng Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Rahul Khairnar

23 papers receiving 303 citations

Peers

Countries citing papers authored by Rahul Khairnar

Since Specialization

Citations

This map shows the geographic impact of Rahul Khairnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Khairnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Khairnar more than expected).

Fields of papers citing papers by Rahul Khairnar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Khairnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Khairnar. The network helps show where Rahul Khairnar may publish in the future.

Co-authorship network of co-authors of Rahul Khairnar

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Khairnar. A scholar is included among the top collaborators of Rahul Khairnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Khairnar. Rahul Khairnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcomes of sacubitril-valsartan versus angiotensin converting enzyme inhibitor or angiotensin receptor blocker among patients with heart failure and ejection fraction at/less than 60 %: A retrospective, observational, parallel cohort, multi-group study 2025 ·Heart & Lung ·Nancy M. Albert, James Bena, Shannon L. Morrison, James B. Williams, (unknown), Rahul Khairnar, Trejeeve Martyn	0
2	Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic 2024 ·JACC Heart Failure ·Aferdita Spahillari, Laura Cohen, (unknown), Yuxi Liu, (unknown), (unknown), (unknown), Rahul Khairnar, Kristin Williamson, Jason H. Wasfy, Nandita S. Scott, (unknown), Stephen J. Greene, Gregg C. Fonarow, James L. Januzzi	13
3	Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry 2020 ·Advances in Radiation Oncology ·Ali Saeed, Rahul Khairnar, Ankur Sharma, Gary Larson, Henry Tsai, (unknown), Lia M. Halasz, Prakash Chinnaiyan, Carlos Vargas, Mark V. Mishra	27
4	Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09 2020 ·Clinical and Translational Radiation Oncology ·Mark V. Mishra, Rahul Khairnar, Søren M. Bentzen, Gary Larson, Henry Tsai, (unknown), Carlos Vargas, George E. Laramore, Carl J. Rossi, L Rosen, Kai Sun, William F. Hartsell	5
5	Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases 2020 ·Radiation Oncology ·(unknown), Jill Remick, Kai Sun, Gregory S. Alexander, Rahul Khairnar, (unknown), (unknown), (unknown), Yannick Poirier, Narottam Lamichhane, S Becker, Shifeng Chen, Jason K. Molitoris, Young Kwok, William F. Regine, Mark V. Mishra	22
6	A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis 2020 ·Radiation Oncology ·Jill Remick, (unknown), Rahul Khairnar, Kai Sun, (unknown), (unknown), Yannick Poirier, Narottam Lamichhane, S Becker, Shifeng Chen, Akshar N. Patel, Young Kwok, E.M. Nichols, Pranshu Mohindra, Graeme F. Woodworth, William F. Regine, Mark V. Mishra	40
7	Real-World Persistence with and Adherence to Emicizumab Prophylaxis in Persons with Hemophilia a: A Secondary Claims Database Analysis 2020 ·Blood ·Arash Mahajerin, Rahul Khairnar, Craig S. Meyer, Ibrahim M. Abbass, Rongrong Wang, (unknown), (unknown), Karina Raimundo	2
8	Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09 2019 ·Clinical and Translational Radiation Oncology ·Mark V. Mishra, Rahul Khairnar, Søren M. Bentzen, Gary Larson, Henry Tsai, (unknown), Carlos Vargas, George E. Laramore, Carl J. Rossi, L Rosen, Mingyao Zhu, William F. Hartsell	13
9	Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation 2019 ·Cureus ·Ankur Sharma, Rahul Khairnar, (unknown), Jill Remick, E.M. Nichols, Pranshu Mohindra, Torunn I. Yock, William F. Regine, Mark V. Mishra	2
10	Patient Prioritization for Proton Beam Therapy in a Cost-Neutral Payer Environment: Use of a Clinical Benefit Score for Resource Allocation 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Amita Sharma, Rahul Khairnar, (unknown), Jill Remick, E.M. Nichols, Pranshu Mohindra, (unknown), William F. Regine, Mark V. Mishra	3
11	Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data 2019 ·Cancer Medicine ·Daisuke Goto, Rahul Khairnar, Jean A. Yared, Candice Yong, Dorothy Romanus, Eberechukwu Onukwugha, Julia F. Slejko	10
12	Barriers and facilitators to diabetes self-management in a primary care setting – Patient perspectives 2018 ·Research in Social and Administrative Pharmacy ·Rahul Khairnar, Khalid M. Kamal, Vincent J. Giannetti, Nilanjana Dwibedi, (unknown)	21
13	Patient-Reported Outcomes (PROs) Comparing Pencil Beam Scanning (PBS) and Double Scatter/Uniform Scanning Proton Beam Therapy for Localized Prostate Cancer (PC): Analysis of PCG 001-09 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Mark V. Mishra, Rahul Khairnar, (unknown), Gary Larson, H.K. Tsai, (unknown), Carlos Vargas, George E. Laramore, Carl J. Rossi, L Rosen, William F. Hartsell	1
14	Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy 2018 ·Practical Radiation Oncology ·Joseph Levy, Rahul Khairnar, Alexander V. Louie, Timothy N. Showalter, C. Daniel Mullins, Mark V. Mishra	17
15	Evaluating the cost-effectiveness of hydrogel spacer in radiotherapy (RT) of prostate cancer (PC). 2018 ·Journal of Clinical Oncology ·Rahul Khairnar, Joseph Levy, Mark V. Mishra	1
16	Barriers and Facilitators to Diabetes Self-Management in a Primary Care Setting: Physician Perspective 2016 ·Value in Health ·Rahul Khairnar, (unknown), (unknown), Vincent J. Giannetti, Nilanjana Dwibedi	1
17	Barriers and Facilitators to Diabetes Self-Management in a Primary Care Setting: Patient Perspective 2016 ·Value in Health ·Rahul Khairnar, (unknown), (unknown), Vincent J. Giannetti, Nilanjana Dwibedi	1
18	Relationship Between Medication Adherence, Disease Severity And Employment Status In Rheumatoid Arthritis 2015 ·Value in Health ·Subrata Ghosh, Khalid M. Kamal, (unknown), Richard T. Miller, (unknown), Rahul Khairnar	0
19	Cost-of-Illness Studies: An Updated Review of Current Methods 2015 ·PharmacoEconomics ·Eberechukwu Onukwugha, (unknown), (unknown), Štefan Varga, Rahul Khairnar, C. Daniel Mullins	73
20	A systematic review of quality of life and caregiver burden in Parkinson's disease 2013 ·Value in Health ·Melanie E. Brewster, (unknown), Rahul Khairnar, Khalid M. Kamal, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact